Genomic imbalances in endometrial adenocarcinomas - Comparison of DNA ploidy, karyotyping and comparative genomic hybridization

Molecular Oncology

Volumn 6, Issue 1, 2012, Pages 98-107

  Kildal, Wanja ^a,b   Micci, Francesca ^a,b   Risberg, Bjørn ^a   Abeler, Vera M ^a   Kristensen, Gunnar B ^a   Heim, Sverre ^a,b,c   Danielsen, Håvard E ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Aneuploidy; Comparative genomic hybridization; DNA ploidy; Endometrial adenocarcinoma; Endometrioid; Karyotyping

Indexed keywords

DNA;

ANEUPLOIDY; ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; KARYOTYPING; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; X CHROMOSOME;

EID: 84856271731     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.10.002     Document Type: Article

References (27)

1. Bardi G., Fenger C., Johansson B., Mitelman F., Heim S. Tumor karyotype predicts clinical outcome in colorectal cancer patients. J. Clin. Oncol. 2004, 13:2623-2634.
2. Bokhman J.V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 1983, 1:10-17.
3. Britton L.C., Wilson T.O., Gaffey T.A., Lieber M.M., Wieand H.S., Podratz K.C. Flow cytometric DNA analysis of stage I endometrial carcinoma. Gynecol. Oncol. 1989, 3:317-322.
4. Geisinger K.R., Homesley H.D., Morgan T.M., Kute T.E., Marshall R.B. Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors. Cancer 1986, 7:1518-1525.
5. Kildal W., Kærn J., Kraggerud S.M., Abeler V.M., Sudbo J., Trope C.G., Lothe R.A., Danielsen H.E. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors-relation to clinicopathologic variables. Cancer Genet. Cytogenet. 2004, 1:25-32.
6. Kristensen G.B., Kildal W., Abeler V.M., Kærn J., Vergote I., Trope C.G., Danielsen H.E. Large-scale genomic instability predicts long-term outcome for women withinvasive stage I ovarian cancer. Ann. Oncol. 2003, 10:1494-1500.
7. Lax S.F., Kendall B., Tashiro H., Slebos R.J., Hedrick L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer 2000, 4:814-824.
8. Micci F., Teixeira M.R., Haugom L., Kristensen G., Abeler V.M., Heim S. Genomic aberrations in carcinomas of the uterine corpus. Genes Chromosomes. Cancer 2004, 3:229-246.
9. Milatovich A., Heerema N.A., Palmer C.G. Cytogenetic studies of endometrial malignancies. Cancer Genet. Cytogenet. 1990, 1:41-53.
10. Mitelman Database of Chromosome Abberations in Cancer 2010, http://cgap.nci.nih.gov/Chromosomes/Mitelman.
11. Nordstrom B., Strang P., Lindgren A., Bergstrom R., Tribukait B. Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications?. Int. J. Gynecol. Pathol. 1996, 3:191-201.
12. Pere H., Tapper J., Wahlstrom T., Knuutila S., Butzow R. Distinct chromosomal imbalances in uterine serous and endometrioid carcinomas. Cancer Res. 1998, 5:892-895.
13. Pisani A.L., Barbuto D.A., Chen D., Ramos L., Lagasse L.D., Karlan B.Y. HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma. Obstet. Gynecol. 1995, 5(Pt 1):729-734.
14. Pradhan M., Abeler V.M., Danielsen H.E., Trope C.G., Risberg B.A. Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas. Mod. Pathol. 2006, 9:1227-1235.
15. Pradhan M., Abeler V.M., Davidson B., Kildal W., Nyboen A., Trope C.G., Risberg B., Danielsen H.E. DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens. Int. J. Gynecol. Pathol. 2010, 6:572-578.
16. Prat J. Prognostic parameters of endometrial carcinoma. Hum. Pathol. 2004, 6:649-662.
17. Ribeiro F.R., Jeronimo C., Henrique R., Fonseca D., Oliveira J., Lothe R.A., Teixeira M.R. 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects. Clin. Cancer Res. 2006, 13:3961-3970.
18. Schulten H.J., Gunawan B., Enders C., Donhuijsen K., Emons G., Fuzesi L. Overrepresentation of 8q in carcinosarcomas and endometrial adenocarcinomas. Am. J. Clin. Pathol. 2004, 4:546-551.
19. Solomon D.A., Kim K., Diaz-Martinez L.A., Fair J., Elkahloun A.G., Harris B.T., Toretsky J.A., Rosenberg S.A., Shulka N., Ladanyi M., Samuels Y., James D., Yu H., Kim J.-S., Waldman T. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 2011, 333:1039-1043.
20. Sonoda G., du M.S., Godwin A.K., Bell D.W., Liu Z., Hogan M., Yakushiji M., Testa J.R. Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization. Genes Chromosomes. Cancer 1997, 2:115-125.
21. Sorbe B., Risberg B., Frankendal B. DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma. Gynecol. Oncol. 1990, 1:22-27.
22. Stendahl U., Strang P., Wagenius G., Bergstrom R., Tribukait B. Prognostic significance of proliferation in endometrial adenocarcinomas: a multivariate analysis of clinical and flow cytometric variables. Int. J. Gynecol. Pathol. 1991, 3:271-284.
23. Suehiro Y., Umayahara K., Ogata H., Numa F., Yamashita Y., Oga A., Morioka H., Ito T., Kato H., Sasaki K. Genetic aberrations detected by comparative genomic hybridization predict outcome in patients with endometrioid carcinoma. Genes Chromosomes. Cancer 2000, 1:75-82.
24. Susini T., Amunni G., Molino C., Carriero C., Rapi S - Branconi F., Branconi F., Marchionni M., Taddei G., Scarselli G. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Cancer 2007, 5:882-890.
25. Suzuki A., Fukushige S., Nagase S., Ohuchi N., Satomi S., Horii A. Frequent gains on chromosome arms 1q and/or 8q in human endometrial cancer. Hum. Genet. 1997, 5-6:629-636.
26. Terada K., Mattson D., Goo D., Shimizu D. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer. Gynecol. Oncol. 2004, 3:483-487.
27. van der Putten H.W., Baak J.P., Koenders T.J., Kurver P.H., Stolk H.G., Stolte L.A. Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma. Cancer 1989, 7:1378-1387.